Hologic, Inc. (HOLX)

Revenue

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep 27, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	2012 - 2021
Diagnostics Revenue	1.83B	Log In	Log In	Log In	Upgrade
Breast Health Revenue	1.48B	Log In	Log In	Log In	Upgrade
GYN Surgical Revenue	679.80M	Log In	Log In	Log In	Upgrade
Skeletal Health Revenue	109.40M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	4.10B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep 27, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	2012 - 2021
Diagnostics Operating Income	-	Log In	Log In	Log In	Upgrade
Breast Health Operating Income	-	Log In	Log In	Log In	Upgrade
GYN Surgical Operating Income	-	Log In	Log In	Log In	Upgrade
Skeletal Health Operating Income	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	714.30M	Log In	Log In	Log In	Upgrade

Capital Expenditures

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep 27, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	2012 - 2021
Diagnostics Capital Expenditures	86.70M	Log In	Log In	Log In	Upgrade
Breast Health Capital Expenditures	19.90M	Log In	Log In	Log In	Upgrade
GYN Surgical Capital Expenditures	25.10M	Log In	Log In	Log In	Upgrade
Skeletal Health Capital Expenditures	400.00K	Log In	Log In	Log In	Upgrade

Updated Nov 3, 2025. Data Source: Fiscal.ai.